Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Monti

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Molecules (Basel, Switzerland)|February 14, 2019
Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST ProtocolAnna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
International Journal of Molecular Sciences|February 24, 2024
State of the Art and New Trends from the Second International StemNet MeetingIvana Ferrero, Filippo Piccinini, Pasquale Marrazzo, et al.
International Journal of Nanomedicine|February 19, 2019
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro studyEmanuela Cova, Laura Pandolfi, Miriam Colombo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
Nature Communications|June 7, 2013
Zscan4 restores the developmental potency of embryonic stem cellsTomokazu Amano, Tetsuya Hirata, Geppino Falco, et al.
Molecules (Basel, Switzerland)|September 13, 2019
Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic CellsLaura Pandolfi, Vanessa Frangipane, Claudia Bocca, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancerAndrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Molecules (Basel, Switzerland)|February 14, 2019
Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST ProtocolAnna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
International Journal of Molecular Sciences|February 24, 2024
State of the Art and New Trends from the Second International StemNet MeetingIvana Ferrero, Filippo Piccinini, Pasquale Marrazzo, et al.
International Journal of Nanomedicine|February 19, 2019
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro studyEmanuela Cova, Laura Pandolfi, Miriam Colombo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
<sup>177</sup>Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
Nature Communications|June 7, 2013
Zscan4 restores the developmental potency of embryonic stem cellsTomokazu Amano, Tetsuya Hirata, Geppino Falco, et al.
Molecules (Basel, Switzerland)|September 13, 2019
Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic CellsLaura Pandolfi, Vanessa Frangipane, Claudia Bocca, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancerAndrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2020
Dosimetry and safety of <sup>177</sup>Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patientsGiovanni Paganelli, Anna Sarnelli, Stefano Severi, et al.
Pageof 9